Rutgers Cancer Institute of New JerseyNew Brunswick, NJ
Disclosures:
1039 - Identifying Patients with Bone Metastases at Highest Risk of Skeletal-Related Events and Understanding Underuse of Bone Modifying Agents: A Retrospective Analysis
Tuesday, October 1, 20248:20 AM – 8:25 AM ET